Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C De Simone

Showing results (251-260 of 262) with videos related to

Pageof 27
Sort By:
European Review for Medical and Pharmacological Sciences|December 11, 2014
Investigating psoriasis awareness among patients in Italy: validation of a questionnaireF Bardazzi, P Amerio, G Amoruso, et al.
Journal of Biological Regulators and Homeostatic Agents|November 28, 2008
Influence of body mass index, comorbidities and prior systemic therapies on the response of psoriasis to adalimumab: an exploratory analysis from the APHRODITE dataN Cassano, A Galluccio, C De Simone, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 9, 2017
Consensus on the management of patients with psoriatic arthritis in a dermatology settingP Gisondi, G Altomare, F Ayala, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 1, 2017
Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasisP Gisondi, G Altomare, F Ayala, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 30, 2022
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experienceG Avallone, F Cavallo, C Astrua, et al.
International Journal of Immunopathology and Pharmacology|March 25, 2009
A multicenter open-label experience on the response of psoriasis to Adalimumab and effect of dose escalation in non-responders: the Aphrodite projectG A Vena, A Galluccio, C De Simone, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 14, 2020
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian studyA Dattola, A Balato, M Megna, et al.
The British Journal of Dermatology|December 23, 2018
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experienceA Conti, F Peccerillo, P Amerio, et al.
Expert Opinion on Biological Therapy|December 18, 2023
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort studyA Chiricozzi, S M Ferrucci, L Di Nardo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2022
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian studyF Bardazzi, F Filippi, M A Chessa, et al.
Pageof 27

Showing results (251-260 of 262) with videos related to

Sort By:
Pageof 27
European Review for Medical and Pharmacological Sciences|December 11, 2014
Investigating psoriasis awareness among patients in Italy: validation of a questionnaireF Bardazzi, P Amerio, G Amoruso, et al.
Journal of Biological Regulators and Homeostatic Agents|November 28, 2008
Influence of body mass index, comorbidities and prior systemic therapies on the response of psoriasis to adalimumab: an exploratory analysis from the APHRODITE dataN Cassano, A Galluccio, C De Simone, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 9, 2017
Consensus on the management of patients with psoriatic arthritis in a dermatology settingP Gisondi, G Altomare, F Ayala, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 1, 2017
Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasisP Gisondi, G Altomare, F Ayala, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 30, 2022
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experienceG Avallone, F Cavallo, C Astrua, et al.
International Journal of Immunopathology and Pharmacology|March 25, 2009
A multicenter open-label experience on the response of psoriasis to Adalimumab and effect of dose escalation in non-responders: the Aphrodite projectG A Vena, A Galluccio, C De Simone, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 14, 2020
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian studyA Dattola, A Balato, M Megna, et al.
The British Journal of Dermatology|December 23, 2018
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experienceA Conti, F Peccerillo, P Amerio, et al.
Expert Opinion on Biological Therapy|December 18, 2023
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort studyA Chiricozzi, S M Ferrucci, L Di Nardo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2022
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian studyF Bardazzi, F Filippi, M A Chessa, et al.
Pageof 27